Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mid-To-Late-Stage Investor Longitude Capital Closes $385M Second Fund

12 Oct 2012

• By Paul Bonanos

Related Content

Life Sciences VCs Leave Morgenthaler, ATV To Form New Fund

31 Oct 2011

Venture Capital Survey Paints Bleak Portrait

01 Oct 2012

Diversification vs. Sector Focus: Longitude, Enterprise Seek Latitude in Life Sciences

01 Mar 2007

Related Companies

Amarin Corp plc

Jazz Pharmaceuticals plc

Corcept Therapeutics Incorporated

Cadence Pharmaceuticals, Inc.

Civitas Therapeutics

Collegium Pharmaceutical, Inc.

Xanodyne Pharmaceuticals, Inc.

Additional Topics

United States Business Strategies Deals BioPharmaceutical Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.